Login / Signup

Impaired ACE2 glycosylation and protease activity in Fabry disease protects from COVID-19.

Ilaria CaputoGiovanni BertoldiGiulia DriussiLuca SgarabottoGianni CarraroLucia Federica StefanelliPaul A DavisLorenzo Arcangelo Calò
Published in: Journal of internal medicine (2023)
Keyphrases
  • coronavirus disease
  • sars cov
  • replacement therapy
  • angiotensin converting enzyme
  • angiotensin ii
  • hypertrophic cardiomyopathy
  • heart failure
  • left ventricular
  • atrial fibrillation